HomeInsightsPE

Ind-swift Ltd PE Ratio

Ind-swift Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

11.3 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Ind-Swift Ltd

NSE: INDSWFTLTD

PE

3

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Ind-Swift Ltd is 3 as of 12 Dec 15:30 PM .
  • The P/E Ratio of Ind-Swift Ltd changed from 1.5 on March 2023 to 7 on March 2024 . This represents a CAGR of 116.02% over 2 years.
  • The Latest Trading Price of Ind-Swift Ltd is ₹ 29.47 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Ind-Swift Ltd

No data available

Company Fundamentals for Ind-Swift Ltd

No data available

Image

Ind-Swift Ltd

NSE: INDSWFTLTD

Share Price

₹ 29.47

-1.26 (-4.10%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Ind-Swift Ltd

1M

1Y

3Y

5Y

Monitoring Ind-Swift Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202430.73
10 Dec 202430.08
09 Dec 202432.35
06 Dec 202426.96
05 Dec 202422.47
04 Dec 202422.26
03 Dec 202421.33
02 Dec 202421.44
29 Nov 202420.59
28 Nov 202420.96

SWOT Analysis Of Ind-Swift Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ind-Swift Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ind-Swift Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Ind-Swift Ltd3166
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Ind-Swift Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ind-Swift Ltd

No data available

* All values are in crore

Historical Revenue of Ind-Swift Ltd

No data available

* All values are in crore

Historical EBITDA of Ind-Swift Ltd

No data available

* All values are in crore

Historical Net Profit of Ind-Swift Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ind-Swift Ltd

No data available

* All values are in %

About Ind-Swift Ltd

  • Ind-Swift Ltd (ISL) is an India-based pharmaceutical company.
  • The company is engaged in the manufacturing and marketing of pharmaceutical finished dosage.
  • The products manufactured by the company include cephalosporins, quinolones, aminoglycosides, macrolides, chloramphenicol, tetracyclines, sulphonamides, antianaerobics and anti-fungals. The company manufactures various dosage forms, including oral solutions and suspensions; dry syrups and hard gelatin capsules; tablets; dermatologicals comprising creams, ointments, and gels; eye and ear drops; and injectables.
  • The company, through their different divisions, markets formulations focusing on the needs of various therapeutic segments, such as diabetology, cardiovascular, anesthesiology, oncology, ophthalmology, neuropsychiatry, gynecology, pediatric, ENT, surgery, internal medicine, dermatology, urology, cardiology, and dental specialty.

Ind-Swift Ltd News Hub

News

Ind-Swift consolidated net profit rises 1096.61% in the June 2024 quarter

Net profit of Ind-Swift rose 1096.61% to Rs 28.24 crore in the quarter ended June 2024 as ...

Read more

2024-08-14 00:00:00

News

Ind-Swift to convene board meeting

Ind-Swift will hold a meeting of the Board of Directors of the Company on 13 August 2024. ...

Read more

2024-08-02 00:00:00

News

Ind-Swift to conduct AGM

Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 3...

Read more

2024-09-03 00:00:00

News

Ind-Swift AGM scheduled

Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 3...

Read more

2024-09-03 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ind-Swift Ltd

What is the current PE Ratio of Ind-Swift Ltd?

The Current PE Ratio of Ind-Swift Ltd is 3.03 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Ind-Swift Ltd last year?

The PE Ratio of Ind-Swift Ltd was 1.5 last year, now the PE ratio is 3.03, showing a year-on-year growth of 102.0%.

What does the PE Ratio of Ind-Swift Ltd indicate about its stock?

The PE Ratio of Ind-Swift Ltd is 3.03. This ratio indicates that investors are willing to pay 3.03 times the earnings per share for each share of Ind-Swift Ltd.

What is the PE Ratio Growth of Ind-Swift Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ind-Swift Ltd grew by 102.0% whereas, the EPS ratio grew by -85.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions